Page 5 - 2021年18期
P. 5
CHINA PHARMACY
Volume 32，Number 18，September 30，2021
Semimonthly
Selected Table of Contents
Benefit Balance and System Construction of Innovation and Accessibility of Pharmaceutical Products in China：
Taking the Patent Linking System as an Example ……………………………… HAN Xinyue，NIE Hongtao（2177）
Construction of Clinical Pharmacist Performance Appraisal System under the New“National Examination”
Situation ……………… WU Yingqi，ZHANG Shengyu，YIN Tong，WU Zhangbao，ZHU Bin，SHEN Aizong（2184）
Content Determination of Potential Genotoxic Impurity Maleic Hydrazide in Azintamide ………………………
…………………………… ZHAO Yuxin，SUN Bingzhe，NI Weixing，LIANG Ranzhi，DI Bin，SU Mengxiang（2189）
Identification of Panax notoginseng and Its Processed Products Based on HPLC and IR Spectrum ………………
……………………………………………………………………………………………… LI Yuxin，XING Na，
ZHANG Zhihong，YU Tianying，MA Enyao，WANG Xue，BAI Haodong，ZENG Yuanning，WANG Qiuhong（2194）
Identification of the Origin of Schizonepeta tenusfolia Based on“Odor”Information ……………………………
………………………………… ZHANG Lixin，YU Xiaocong，WANG Zekun，MAO Chunqin，SHU Yachun（2203）
Effects of Dexmedetomidine on Ventricular Arrhythmia in Myocardial Hypertrophy Model Rabbits and CaMKⅡ
Expression in Cardiac Tissue …………………………… LIU Xudong，ZHAO Liang，CAO Xuefeng，HU Jie（2209）
Determination of the Contents of Heavy Metals and Harmful Elements in Pediatric，Paracetamol，Atificial Cow-
bezoar and Chlorphenamine Maleate Granules by ICP-MS ………………………………………………………
……………………………………………… PENG Shuang，YANG Haiyuan，ZHANG Minjuan，WEI Wenzhi（2218）
Establishment of the Microwave Processing Technology of Yellow Wine-processed Curculigo orchioides and
Comparison with Traditional Technology …………… LI Yuanyuan，WANG Wei，JU Chengguo，JIA Tianzhu（2223）
Study on the Prevention Mechanism of Anti-tuberculosis Drug-induced Liver Injury with Orazamide Based on
HMGB1-RAGE Signaling Pathway………………………………… HE Ling，TANG Jian，PENG Zhongtian（2230）
Establishment of Modified Aqueous Two-phase Extraction System of Polyphenols from Archidendron clypearia
………………………………… GU Lixia，FU Yongmei，ZHANG Shu，LIN Juyi，DENG Hong，LU Yongmei（2236）
Cause Analysis of“Not Cost-effective at a Zero Price”Results in Pharmacoeconomic Evaluation ………………
……………………………………………………………………… GUAN Xin，WANG Luying，LI Hongchao（2242）
Determination of 20（S）-protopanaxadiol Concentration in Human Plasma by UPLC-MS/MS ……………………
………………… LIU Shenglan，TANG Zhi，CHEN Lei，WU Sufen，ZHOU Ling，LIAO Yinjuan，ZHANG Jie（2248）
Effects of Lidocaine Aerosol Inhalation on Perioperative Pulmonary Function，Inflammatory Factors and Related
Complication of Patients with One-lung Ventilation …… TAO Guanghua，WU Yong，GE Huashun，YU Buwei（2254）
Meta-analysis of the Safety of Meropenem for Neonatal Infection …………………………………………………
………………………………………………………………… ZHEN Lulu，LIU Lu，LIU Chang，YAN Meixing（2260）
Analysis of a Rare Case of Cerebral Infarction Secondary to Anaphylactic Shock Caused by Nicotinic Acid
Injection …………………………………………………………………………………… YANG Ping，AN Wei（2267）
Discussion on the Optimization of Pre-review Rules for PASS System in Our Hospital：Taking Calcineurin
Inhibitor as an Example ………………………………………………… MA Zhuyue，GU Jie，YUAN Hongyu（2271）
